These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 26501411)
1. Hemodynamic Thresholds for Precapillary Pulmonary Hypertension. Gerges C; Gerges M; Skoro-Sajer N; Zhou Y; Zhang L; Sadushi-Kolici R; Jakowitsch J; Lang MB; Lang IM Chest; 2016 Apr; 149(4):1061-73. PubMed ID: 26501411 [TBL] [Abstract][Full Text] [Related]
2. Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry. Bergot E; Sitbon O; Cottin V; Prévot G; Canuet M; Bourdin A; de Groote P; Rottat L; Gressin V; Jaïs X; Humbert M; Simonneau G Int J Cardiol; 2014 Apr; 172(3):561-7. PubMed ID: 24529947 [TBL] [Abstract][Full Text] [Related]
3. Clinical Relevance of Fluid Challenge in Patients Evaluated for Pulmonary Hypertension. D'Alto M; Romeo E; Argiento P; Motoji Y; Correra A; Di Marco GM; Iacono AM; Barracano R; D'Andrea A; Rea G; Sarubbi B; Russo MG; Naeije R Chest; 2017 Jan; 151(1):119-126. PubMed ID: 27575357 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of pulmonary capillary wedge pressure as a correlate of left ventricular filling pressures in pulmonary arterial hypertension. Oliveira RK; Ferreira EV; Ramos RP; Messina CM; Kapins CE; Silva CM; Ota-Arakaki JS J Heart Lung Transplant; 2014 Feb; 33(2):157-62. PubMed ID: 24268673 [TBL] [Abstract][Full Text] [Related]
5. Differential response to intravenous prostacyclin analog therapy in patients with pulmonary arterial hypertension. Walkey AJ; Fein D; Horbowicz KJ; Farber HW Pulm Pharmacol Ther; 2011 Aug; 24(4):421-5. PubMed ID: 21251994 [TBL] [Abstract][Full Text] [Related]
6. Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil. Ascha M; Zhou X; Rao Y; Minai OA; Tonelli AR Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28643420 [TBL] [Abstract][Full Text] [Related]
7. Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure. Naeije R; Gerges M; Vachiery JL; Caravita S; Gerges C; Lang IM Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912263 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials. Benza RL; Gomberg-Maitland M; Naeije R; Arneson CP; Lang IM J Heart Lung Transplant; 2011 Sep; 30(9):982-9. PubMed ID: 21531577 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension. Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478 [TBL] [Abstract][Full Text] [Related]